Search research articles
Contact Us
Filters
Showing results (11-20 of 84) with videos related to
Page
of 9
Sort By:
Prostate Cancer and Prostatic Diseases
|
September 2, 2018
The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort
Axel Möller, Henrik Olsson, Henrik Grönberg, et al.
European Urology Focus
|
July 30, 2017
Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 Model
Tobias Nordström, Henrik Grönberg, Jan Adolfsson, et al.
European Urology
|
January 15, 2018
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential
Peter Ström, Tobias Nordström, Markus Aly, et al.
Scandinavian Journal of Urology
|
December 2, 2015
A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies
Tobias Nordström, Ola Bratt, Joakim Örtegren, et al.
European Urology
|
October 23, 2012
Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011
Tobias Nordström, Markus Aly, Mark S Clements, et al.
European Urology Oncology
|
August 15, 2019
A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging
Thorgerdur Palsdottir, Tobias Nordström, Markus Aly, et al.
European Urology Focus
|
February 14, 2018
Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort Study
Markus Aly, Mark Clements, Caroline E Weibull, et al.
BMC Cancer
|
August 27, 2020
The CanMoRe trial - evaluating the effects of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer: the study protocol of a randomised controlled trial
Andrea Porserud, Patrik Karlsson, Elisabeth Rydwik, et al.
Scandinavian Journal of Urology
|
December 27, 2019
Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml
Jan Chandra Engel, Thorgerdur Palsdottir, Markus Aly, et al.
JAMA Oncology
|
May 19, 2022
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
Lars Björnebo, Tobias Nordström, Andrea Discacciati, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 84) with videos related to
Sort By:
Page
of 9
Prostate Cancer and Prostatic Diseases
|
September 2, 2018
The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort
Axel Möller, Henrik Olsson, Henrik Grönberg, et al.
European Urology Focus
|
July 30, 2017
Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 Model
Tobias Nordström, Henrik Grönberg, Jan Adolfsson, et al.
European Urology
|
January 15, 2018
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential
Peter Ström, Tobias Nordström, Markus Aly, et al.
Scandinavian Journal of Urology
|
December 2, 2015
A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies
Tobias Nordström, Ola Bratt, Joakim Örtegren, et al.
European Urology
|
October 23, 2012
Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011
Tobias Nordström, Markus Aly, Mark S Clements, et al.
European Urology Oncology
|
August 15, 2019
A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging
Thorgerdur Palsdottir, Tobias Nordström, Markus Aly, et al.
European Urology Focus
|
February 14, 2018
Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort Study
Markus Aly, Mark Clements, Caroline E Weibull, et al.
BMC Cancer
|
August 27, 2020
The CanMoRe trial - evaluating the effects of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer: the study protocol of a randomised controlled trial
Andrea Porserud, Patrik Karlsson, Elisabeth Rydwik, et al.
Scandinavian Journal of Urology
|
December 27, 2019
Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml
Jan Chandra Engel, Thorgerdur Palsdottir, Markus Aly, et al.
JAMA Oncology
|
May 19, 2022
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
Lars Björnebo, Tobias Nordström, Andrea Discacciati, et al.
Page
of 9